Single-use Bioprocessing Market to Reach $33.67 Billion by 2030

Single-use Bioprocessing Market by Product (Equipment [Bioreactors, Filtration, Chromatography], Consumables [Filters, Bags, Assemblies, Sensors]), Application (Storage, Mixing), Workflow (Upstream), Molecule Type (mAbs, Vaccines) - Global Forecast to 2030
According to MarketsandMarkets Trademark , the global Single-use Bioprocessing Market [https://www.marketsandmarkets.com/Market-Reports/single-use-bioprocessing-market-231651297.html?utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] is set for substantial expansion, projected to grow from USD 18.01 billion in 2025 to USD 33.67 billion by 2030, at a CAGR of 13.3%. As biopharmaceutical companies prioritize agility, cost efficiency, and scalability, single-use technologies are becoming central to next-generation manufacturing strategies.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=231651297 [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=231651297&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]

Browse

* 740 Market Data Tables
* 65 Figures
* 570 Pages and in-depth TOC on " Single-use Bioprocessing Market - Global Forecast to 2030".

What is fueling this rapid adoption?

The increasing reliance on contract development and manufacturing organizations (CDMOs) and contract manufacturing organizations (CMOs) is a key driver. These organizations require flexible, scalable, and contamination-free systems to meet dynamic production demands. Single-use bioprocessing solutions eliminate the need for extensive cleaning and validation, significantly reducing turnaround times and operational complexity.

Why does this matter for industry leaders? The shift toward biologics, biosimilars, and advanced therapies including cell and gene therapies is reshaping production requirements. Single-use systems offer lower capital investment compared to traditional stainless-steel infrastructure, enabling faster facility setup and improved return on investment. Additionally, the reduced risk of cross-contamination enhances product safety and regulatory compliance critical priorities for executives managing global supply chains.

How is technology enhancing efficiency?

Advancements in automation, integrated monitoring systems, and process analytics are improving productivity and enabling real-time decision-making. These innovations are helping manufacturers optimize workflows, ensure consistent quality, and scale production more effectively.

From an equipment perspective, single-use bioreactors accounted for the largest market share in 2024. What makes them the preferred choice? These systems support rapid deployment, standardized operations, and seamless scalability from development to GMP manufacturing. Their closed processing environments, compatibility with single-use sensors, and reduced cleaning requirements enable predictable and efficient production particularly in upstream processes.

In terms of application, the cell culture segment is expected to register the highest CAGR during the forecast period. Why is cell culture driving growth? The increasing focus on culture-intensive modalities such as monoclonal antibodies (mAbs), viral vectors, and mRNA therapies is significantly boosting demand. As pipelines expand, the need for scalable and efficient cell culture processes is rising, making single-use systems indispensable for modern biopharmaceutical manufacturing.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=231651297 [https://www.marketsandmarkets.com/requestsampleNew.asp?id=231651297&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr]

Regional Insights:

Asia Pacific is projected to be the fastest-growing region in the single-use bioprocessing market. What is driving this momentum? Increasing demand for biosimilars, rising investments by biopharmaceutical companies and CMOs, and the expansion of healthcare infrastructure in emerging economies are key factors. Governments and private players in the region are actively investing in advanced manufacturing capabilities, positioning Asia Pacific as a critical growth hub.

Competitive Landscape:

Leading players in the single-use bioprocessing market include Sartorius AG, Danaher Corporation, Thermo Fisher Scientific, Inc., Merck KGaA, Avantor, Inc., Repligen Corporation, Entegris, Getinge AB, Parker Hannifin Corporation, Alfa Laval Corporate AB, Saint-Gobain, Eppendorf SE, Corning Incorporated, Eaton Corporation plc, METTLER TOLEDO, Porvair PLC, Lonza, and ABEC, Inc. These companies are actively investing in innovation, strategic partnerships, and capacity expansion to strengthen their market positions.

Related Reports:

Single Use Assemblies Market [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=46226549&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] - Global Forecast to 2029

Single-use Bioreactors Market [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=49113750&utm_source=abnewswire.com&utm_medium=referral&utm_campaign=paidpr] - Global Forecast to 2029

Media Contact
Company Name: MarketsandMarkets Trademark Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=singleuse-bioprocessing-market-to-reach-3367-billion-by-2030]
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/single-use-bioprocessing-market-231651297.html

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.